150 related articles for article (PubMed ID: 32787377)
1. Successful thrombolytic therapy in acute ischemic stroke after reversal of warfarin: a case report.
Qiu G; Yan YD; Zhang XF; Shen M; Qian J; Ma XD; Gu ZC
Ann Palliat Med; 2021 May; 10(5):5813-5817. PubMed ID: 32787377
[TBL] [Abstract][Full Text] [Related]
2. Reversal of Vitamin K Antagonist Therapy Before Thrombolysis for Acute Ischemic Stroke.
Chausson N; Soumah D; Aghasaryan M; Altarcha T; Alecu C; Smadja D
Stroke; 2018 Oct; 49(10):2526-2528. PubMed ID: 30355096
[TBL] [Abstract][Full Text] [Related]
3. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
Mowla A; Memon A; Razavi SM; Lail NS; Vaughn CB; Mohammadi P; Sawyer RN; Shirani P
J Stroke Cerebrovasc Dis; 2021 May; 30(5):105678. PubMed ID: 33640783
[TBL] [Abstract][Full Text] [Related]
4. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
Šaňák D; Jakubíček S; Černík D; Herzig R; Kunáš Z; Mikulík R; Ostrý S; Reif M; Rohan V; Tomek A; Veverka T
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2479-2483. PubMed ID: 29807757
[TBL] [Abstract][Full Text] [Related]
5. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
6. Idarucizumab for Intravenous Thrombolysis and Endovascular Thrombectomy in Acute Stroke: A Case Report.
Lin YT; Lai YJ; Lai TH
J Emerg Med; 2020 Mar; 58(3):e113-e116. PubMed ID: 31744711
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of coagulation factor XIII on bleeding risk in ischemic stroke patients treated with intravenous thrombolysis.
Zhang L; Zhang C; Luo Y; Tang N
Ann Palliat Med; 2021 Jul; 10(7):7579-7586. PubMed ID: 34353045
[TBL] [Abstract][Full Text] [Related]
8. Nonatrial Fibrillation was Associated With Early Neurological Improvement After Intravenous Thrombolysis With rt-PA in Patients With Acute Ischemic Stroke.
Liu J; Huang J; Xu H; Dai H
Neurologist; 2020 Mar; 25(2):28-32. PubMed ID: 32132497
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Values of Prothrombin Time and Inflammation-Related Parameter in Acute Ischemic Stroke Patients After Intravenous Thrombolysis with rt-PA.
Zhao J; Dong L; Hui S; Lu F; Xie Y; Chang Y; Yang B
Clin Appl Thromb Hemost; 2023; 29():10760296231198042. PubMed ID: 37670481
[TBL] [Abstract][Full Text] [Related]
10. Safety and Effectiveness of Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in 80 Years and Older Acute Ischemic Stroke Patients.
Chen Y; Li CH; Wang YX; Zhang CH; Dong Z; Zhang FF; Wang JH; Zhang PL
Cell Biochem Biophys; 2015 Jul; 72(3):883-8. PubMed ID: 27352190
[TBL] [Abstract][Full Text] [Related]
11. Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report.
Ohtani T; Sintoku R; Yajima T; Kaneko N
J Med Case Rep; 2019 Dec; 13(1):390. PubMed ID: 31875786
[TBL] [Abstract][Full Text] [Related]
12. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
[TBL] [Abstract][Full Text] [Related]
13. Warfarin anticoagulation exacerbates the risk of hemorrhagic transformation after rt-PA treatment in experimental stroke: therapeutic potential of PCC.
Pfeilschifter W; Spitzer D; Pfeilschifter J; Steinmetz H; Foerch C
PLoS One; 2011; 6(10):e26087. PubMed ID: 22039437
[TBL] [Abstract][Full Text] [Related]
14. rt-PA with remote ischemic postconditioning for acute ischemic stroke.
Che R; Zhao W; Ma Q; Jiang F; Wu L; Yu Z; Zhang Q; Dong K; Song H; Huang X; Ji X
Ann Clin Transl Neurol; 2019 Feb; 6(2):364-372. PubMed ID: 30847368
[TBL] [Abstract][Full Text] [Related]
15. Multimode Computed-Tomography-Guided Thrombolysis under a Prolonged Time Window in Acute Ischemic Stroke Patients with Atrial Fibrillation.
Yang Y; Sun W; Li D; Li XY; Wang XT; Li SC; Zhao HJ; Zhang JB
Int Heart J; 2019 Jul; 60(4):822-829. PubMed ID: 31257338
[TBL] [Abstract][Full Text] [Related]
16. Consensus statement on the use of intravenous recombinant tissue plasminogen activator to treat acute ischemic stroke by the Chinese Stroke Therapy Expert Panel.
Xu AD; Wang YJ; Wang DZ;
CNS Neurosci Ther; 2013 Aug; 19(8):543-8. PubMed ID: 23710819
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of IA thrombolysis for acute ischemic stroke among anticoagulated patients.
Janjua N; Alkawi A; Georgiadis A; Suri MF; Ibrahim MS; Kirmani JF; Qureshi AI
Neurocrit Care; 2007; 7(2):152-5. PubMed ID: 17668156
[TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of intravenous thrombolysis with recombinant tissue plasminogen activator in eighty years and older acute ischemic stroke patients.
Chen Y; Li CH; Wang YX; Zhang CH; Dong Z; Zhang FF; Wang JH; Zhang PL
Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1852-8. PubMed ID: 26044231
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
Fan Y; Liao X; Pan Y; Dong K; Wang Y; Wang Y;
J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863
[TBL] [Abstract][Full Text] [Related]
20. Reversal of Oral Vitamin K Antagonists Using Prothrombin Complex Concentration Prior to IV tPA Administration.
Salt I; Aslan IK; Özgenç Biçer Çİ; Gözke E
Neurol India; 2022; 70(3):1238-1239. PubMed ID: 35864677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
